ARTIVION INC (AORT)
US2289031005 - Common Stock
AORT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 195 industry peers in the Health Care Equipment & Supplies industry. The financial health of AORT is average, but there are quite some concerns on its profitability. While showing a medium growth rate, AORT is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
AORT had negative earnings in the past year.
AORT had a positive operating cash flow in the past year.
AORT had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AORT reported negative operating cash flow in multiple years.
1.2 Ratios
AORT has a Return On Assets of -3.86%. This is in the better half of the industry: AORT outperforms 64.10% of its industry peers.
AORT has a Return On Equity of -10.85%. This is in the better half of the industry: AORT outperforms 63.08% of its industry peers.
With a decent Return On Invested Capital value of 1.77%, AORT is doing good in the industry, outperforming 71.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.86% | ||
| ROE | -10.85% | ||
| ROIC | 1.77% |
ROA(3y)-2.74%
ROA(5y)-2.01%
ROE(3y)-7.49%
ROE(5y)-5.38%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AORT has a Operating Margin of 4.66%. This is in the better half of the industry: AORT outperforms 70.77% of its industry peers.
In the last couple of years the Operating Margin of AORT has declined.
With a decent Gross Margin value of 64.74%, AORT is doing good in the industry, outperforming 67.18% of the companies in the same industry.
In the last couple of years the Gross Margin of AORT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.66% | ||
| PM (TTM) | N/A | ||
| GM | 64.74% |
OM growth 3Y10.94%
OM growth 5Y-6.03%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.77%
GM growth 5Y-0.33%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AORT is destroying value.
The number of shares outstanding for AORT has been increased compared to 1 year ago.
Compared to 5 years ago, AORT has more shares outstanding
Compared to 1 year ago, AORT has an improved debt to assets ratio.
2.2 Solvency
AORT has an Altman-Z score of 1.79. This is a bad value and indicates that AORT is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.79, AORT is in the better half of the industry, outperforming 60.51% of the companies in the same industry.
AORT has a debt to FCF ratio of 27.29. This is a negative value and a sign of low solvency as AORT would need 27.29 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 27.29, AORT is in the better half of the industry, outperforming 70.26% of the companies in the same industry.
AORT has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.10, AORT is doing worse than 78.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | 27.29 | ||
| Altman-Z | 1.79 |
ROIC/WACC0.18
WACC10.06%
2.3 Liquidity
AORT has a Current Ratio of 4.85. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
AORT has a Current ratio of 4.85. This is in the better half of the industry: AORT outperforms 68.21% of its industry peers.
AORT has a Quick Ratio of 3.43. This indicates that AORT is financially healthy and has no problem in meeting its short term obligations.
AORT has a Quick ratio of 3.43. This is in the better half of the industry: AORT outperforms 63.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.85 | ||
| Quick Ratio | 3.43 |
3. Growth
3.1 Past
AORT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.22%.
AORT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.82%.
Measured over the past years, AORT shows a small growth in Revenue. The Revenue has been growing by 6.14% on average per year.
EPS 1Y (TTM)-57.22%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-300%
Revenue 1Y (TTM)12.82%
Revenue growth 3Y11.81%
Revenue growth 5Y6.14%
Revenue growth Q2Q17.98%
3.2 Future
The Earnings Per Share is expected to grow by 33.11% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 10.42% on average over the next years. This is quite good.
EPS Next Y59.45%
EPS Next 2Y46.3%
EPS Next 3Y33.11%
EPS Next 5YN/A
Revenue Next Year10.99%
Revenue Next 2Y10.54%
Revenue Next 3Y10.42%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AORT. In the last year negative earnings were reported.
Also next year AORT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
AORT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AORT is cheaper than 73.33% of the companies in the same industry.
74.36% of the companies in the same industry are more expensive than AORT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 76.79 | ||
| EV/EBITDA | 28.27 |
4.3 Compensation for Growth
A more expensive valuation may be justified as AORT's earnings are expected to grow with 33.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.3%
EPS Next 3Y33.11%
5. Dividend
5.1 Amount
AORT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ARTIVION INC
NYSE:AORT (4/24/2024, 9:14:29 AM)
20.98
+0.2 (+0.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap875.08M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.86% | ||
| ROE | -10.85% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 4.66% | ||
| PM (TTM) | N/A | ||
| GM | 64.74% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.1 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.85 | ||
| Quick Ratio | 3.43 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-57.22%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y59.45%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.82%
Revenue growth 3Y11.81%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y